글로벌 반도체 선도기업인 아나로그디바이스(ADI)와 바이오 플랫폼 혁신 기업인 플래그십 파이어니어링(Flagship Pioneering)이 응용 생물학 및 공학 분야에 대한 양사의 상보적인 전문성을 활용해 여러 디지털 생물학 플랫폼 회사 설립 및 강화에 본격 나선다.

▲ADI CEO and Chairman of the Board Vincent Roche (left) and Flagship Pioneering founder and CEO Dr. Noubar Afeyan (right) talk on stage at ADI's General Technical Conference (GTC) event held in Boston, Massachusetts, USA on April 25, 2024.
Strategic partnership with Flagship Pioneer
Global semiconductor leader Analog Devices (ADI) and bio platform innovator Flagship Pioneering are joining forces to build and strengthen multiple digital biology platform companies, leveraging their complementary expertise in applied biology and engineering.
ADI announced today that it has entered into a strategic partnership with Flagship Pioneer to accelerate the development of a fully digitalized biological world.
This partnership between the two companies is expected to accelerate the discovery of biological insights, new and improved measurements, diagnostics and new treatment modalities by combining ADI’s analog and digital semiconductor engineering expertise with Flagship Pioneer’s applied biology expertise.
In particular, this partnership is expected to leverage Flagship Pioneering’s unique innovation process and ADI’s cutting-edge semiconductor technology, signal processing portfolio, and expertise in the physical world domain to develop highly innovative solutions and create new companies in the digital biology field.
Initial focus areas are said to be bioelectronic platforms, regenerative agriculture, emerging applications of artificial intelligence/machine learning (AI/ML), and proactive health and medicine.
Future advancements are expected in the fields of next-generation protein sequencing, multi-omics, early disease diagnosis, converting large-scale biological information into actionable digital data, and new drug design and optimization.
This partnership is the latest project from Pioneer’s flagship Enabling Technologies Initiative, which focuses on supporting and enhancing cutting-edge technologies to develop new therapeutic approaches.
“ADI exists to accelerate the innovations that enrich our lives and the world around us,” said Vincent Roche, ADI Chairman and CEO. “Breakthrough technologies have the potential to enable better preventive care. We anticipate that this digital biology partnership with Flagship Pioneering will place the Intelligent Edge at the center of data-driven healthcare solution innovation for today’s biggest challenges.”
“Thanks to technological leaps and deeper biological understanding, we have entered a new era of biomedical and life sciences innovation, positioning us to make greater progress to improve the health of people and our planet,” said Dr. Noubar Afeyan, founder and CEO of Flagship Pioneering. “Flagship and ADI have complementary strengths and a shared ambition to accelerate the development of a fully digital biological world that harnesses nature’s intelligence to create preventative and therapeutic medicines, regenerative agriculture, and solutions to the threats of climate change.”